Smith Nephew Company Leadership
| SNN Stock | USD 32.88 0.11 0.33% |
Smith Nephew employs about 17 K people. The company is managed by 42 executives with a total tenure of roughly 207 years, averaging almost 4.0 years of service per executive, having 404.76 employees per reported executive. Analysis of Smith Nephew's management performance can provide insight into the firm performance.
| Roland Diggelmann CEO Chief Executive Officer, Executive Director |
| Roberto Quarta Chairman Non-Executive Independent Chairman of the Board |
Smith Nephew Management Team Effectiveness
The company has Return on Asset of 0.0581 % which means that on every $100 spent on assets, it made $0.0581 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0914 %, implying that it generated $0.0914 on every 100 dollars invested. Smith Nephew's management efficiency ratios could be used to measure how well Smith Nephew manages its routine affairs as well as how well it operates its assets and liabilities.Smith Nephew Workforce Comparison
Smith Nephew SNATS is currently regarded as top stock in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 62,476. Smith Nephew totals roughly 17,000 in number of employees claiming about 27% of equities under Health Care industry.
The company has Net Profit Margin of 0.08 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.14 %, which entails that for every 100 dollars of revenue, it generated $0.14 of operating income. Smith Nephew SNATS Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Smith Nephew SNATS Price Series Summation is a cross summation of Smith Nephew price series and its benchmark/peer.
Smith Nephew Notable Stakeholders
A Smith Nephew stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Smith Nephew often face trade-offs trying to please all of them. Smith Nephew's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Smith Nephew's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Deepak Nath | Chief Executive Officer | Profile | |
| Roland Diggelmann | Chief Executive Officer, Executive Director | Profile | |
| Roberto Quarta | Non-Executive Independent Chairman of the Board | Profile | |
| Skip Kiil | President - Orthopedics | Profile | |
| Bradley Cannon | President Orthopaedics | Profile | |
| Simon Fraser | President - Advanced Wound Management and Global Commercial Operations | Profile | |
| Scott Schaffner | President Medicine | Profile | |
| Paul Connolly | President Operations | Profile | |
| Phil Cowdy | Executive Vice President of Business Development & Corporate Affairs | Profile | |
| Mark Gladwell | President - Global Operations and Global Business Services | Profile | |
| Vasant Padmanabhan | President - Research & Development | Profile | |
| Brad Cannon | President - Sports Medicine & ENT | Profile | |
| Ian Melling | Interim Chief Financial Officer | Profile | |
| Bob White | Non-Executive Independent Director | Profile | |
| Erik Engstrom | Non-Executive Independent Director | Profile | |
| Marc Owen | Non-Executive Independent Director | Profile | |
| AnneFrancoise Nesmes | Chief Financial Officer, Executive Director | Profile | |
| Vinita Bali | Non-Executive Independent Director | Profile | |
| John Rogers | CFO Director | Profile | |
| Katarzyna MazurHofsaess | Non-Executive Independent Director | Profile | |
| Rick Medlock | Non-Executive Independent Director | Profile | |
| Robin Freestone | Senior Non-Executive Independent Director | Profile | |
| Virginia Bottomley | Non-Executive Independent Director | Profile | |
| Angie Risley | Non-Executive Independent Director | Profile | |
| John Ma | Non-Executive Independent Director | Profile | |
| Alison Parkes | Chief Officer | Profile | |
| Ajay Dhankhar | Chief Officer | Profile | |
| Helen Barraclough | Company Counsel | Profile | |
| Elga Lohler | Chief Human Resource Officer | Profile | |
| Charles Reynolds | Head Communication | Profile | |
| Cathy ORourke | Chief Legal and Compliance Officer | Profile | |
| Joe Metzger | Senior Communications | Profile | |
| Peter Coenen | President - EMEA Region | Profile | |
| Myra Eskes | President - Asia Pacific | Profile | |
| Andrew Swift | Vice Relations | Profile | |
| Ian FCA | Senior Finance | Profile | |
| Susan Swabey | Company Secretary | Profile | |
| Melissa Guerdan | Chief Quality and Regulatory Affairs Officer | Profile | |
| Philip Cowdy | Chief Officer | Profile | |
| Steve Kane | Global US | Profile | |
| Jo Hallas | Non-Executive Director | Profile | |
| Catheryn ORourke | Chief Legal and Compliance Officer | Profile |
About Smith Nephew Management Performance
The success or failure of an entity such as Smith Nephew SNATS often depends on how effective the management is. Smith Nephew management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Smith management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Smith management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Smith Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. Smith Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom. Smith Nephew operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 18000 people.
Smith Nephew Workforce Analysis
Traditionally, organizations such as Smith Nephew use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Smith Nephew within its industry.Smith Nephew Manpower Efficiency
Return on Smith Nephew Manpower
| Revenue Per Employee | 341.8K | |
| Revenue Per Executive | 138.3M | |
| Net Income Per Employee | 24.2K | |
| Net Income Per Executive | 9.8M | |
| Working Capital Per Employee | 170K | |
| Working Capital Per Executive | 68.8M |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Smith Nephew SNATS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Smith Nephew. If investors know Smith will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Smith Nephew listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Smith Nephew SNATS is measured differently than its book value, which is the value of Smith that is recorded on the company's balance sheet. Investors also form their own opinion of Smith Nephew's value that differs from its market value or its book value, called intrinsic value, which is Smith Nephew's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Smith Nephew's market value can be influenced by many factors that don't directly affect Smith Nephew's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Smith Nephew's value and its price as these two are different measures arrived at by different means. Investors typically determine if Smith Nephew is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Smith Nephew's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.